• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Experian Health Launches AI-Driven Predictive Denials Management

Share:

February 21, 2023

What You Should Know:

– Experian Health launches a new AI-Powered solution, AI Advantage that will help providers recoup the billions in lost dollars due to insurance claim denials.

– These new solutions leverage AI and help healthcare providers prioritize their claims reimbursement process and decrease denials overall, saving time and money across the entire healthcare value chain and ultimately improving care and service for patient consumers.

AI Advantage

One of the top contributors to wasted healthcare dollars is due to the claims process, reported at more than $250 billion per year. Additionally, 35 percent of hospitals and health systems report $50 million or more in foregone revenue as a result of denied claims once appeals have been exhausted. In fact, up to 65 percent of denied claims are never resubmitted.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Experian Health’s AI Advantage encompasses two products that optimize the current claims process through automation and arms providers with real-time insights to avoid unnecessary denials with greater speed and efficiency. The two products can be implemented separately or combined for the pre-claim submission and post-denial processes:

AI Advantage – Predictive Denials evaluates each claim and its likelihood of being denied while also providing insights back to the provider in their existing workflow systems to help determine which item(s) on the claim are the leading cause for denial before submitting. This allows the right specialist to intervene before claims go to payers with a “clean” submission. The product also leverages large-scale historic payment data tuned to providers’ denial trends for continuous learning and adaptation.

AI Advantage – Denial Triage helps providers focus efforts on denials based on their potential and likelihood for yield, automating decision-making for providers. The predictive algorithm evaluates the probability a denial will be overturned and integrates the probability scores directly into existing work queues. This allows providers to focus their efforts on where they are most likely to have a positive result.

By leveraging AI Advantage products, healthcare organizations can streamline the claim reimbursement process and better apply their resources to their ultimate mission in caregiving. This impact can trickle down to patients as well, preventing higher out-of-pocket costs as a result of a denied claim.

Availability

AI Advantage™ is available to be implemented via Experian Health’s ClaimSource® claims management system

Source: Hitconsultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Pharma Regulatory Management Systems Market with Coronavirus (covid-19) Impact Analysis | Also Industry is Booming Worldwide with Key Players | Instem (samarind), Nnit, Extedo, Amplexor, MastercontrolPharma Regulatory Management Systems Market with Coronavirus (covid-19) Impact Analysis | Also Industry is Booming Worldwide with Key Players | Instem (samarind), Nnit, Extedo, Amplexor, Mastercontrol
  • NVIDIA Launches New Computational Infrastructure for Medical Devices, RoboticsNVIDIA Launches New Computational Infrastructure for Medical Devices, Robotics
  • Use-case selection will make or break your AI strategy in healthcareUse-case selection will make or break your AI strategy in healthcare
  • AbbVie Completes Acquisition of ImmunoGen.AbbVie Completes Acquisition of ImmunoGen.
  • Internet of Things, AI to Play Key Role in Future Smart HospitalsInternet of Things, AI to Play Key Role in Future Smart Hospitals
  • Alvotech, Global Biotech Company, and Oaktree Acquisition Corp. Ii Announce June 7, 2022 Extraordinary General Meeting to Approve Business Combination
  • Fuse Medical, Inc. Completes Acquisition of Maxim SurgicalFuse Medical, Inc. Completes Acquisition of Maxim Surgical
  • Clover Health’s new subsidiary will rely on members, machine learning to fuel drug developmentClover Health’s new subsidiary will rely on members, machine learning to fuel drug development

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications